c-Myc activation promotes cofilin-mediated F-actin cytoskeleton remodeling and telomere homeostasis as a response to oxidant-based DNA damage in medulloblastoma cells

Redox Biology - Tập 24 - Trang 101163 - 2019
Anna Lewinska1, Jolanta Klukowska-Rötzler2,3, Anna Deregowska4, Jagoda Adamczyk-Grochala1, Maciej Wnuk4
1Department of Cell Biochemistry, Faculty of Biotechnology, University of Rzeszow, Poland
2Division of Pediatric Hematology/Oncology, University Hospital, Bern, Switzerland
3Department of Emergency Medicine, University Hospital Bern, Switzerland
4Department of Genetics, Faculty of Biotechnology, University of Rzeszow, Pigonia 1, 35-310 Rzeszow, Poland

Tài liệu tham khảo

Louis, 2007, The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol., 114, 97, 10.1007/s00401-007-0243-4 Gerber, 2014, Recent developments and current concepts in medulloblastoma, Cancer Treat Rev., 40, 356, 10.1016/j.ctrv.2013.11.010 Taylor, 2012, Molecular subgroups of medulloblastoma: the current consensus, Acta Neuropathol., 123, 465, 10.1007/s00401-011-0922-z Kool, 2012, Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas, Acta Neuropathol., 123, 473, 10.1007/s00401-012-0958-8 Kool, 2008, Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features, PLoS One, 3, e3088, 10.1371/journal.pone.0003088 Northcott, 2012, Subgroup-specific structural variation across 1,000 medulloblastoma genomes, Nature, 488, 49, 10.1038/nature11327 Pugh, 2012, Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations, Nature, 488, 106, 10.1038/nature11329 Robinson, 2012, Novel mutations target distinct subgroups of medulloblastoma, Nature, 488, 43, 10.1038/nature11213 Remke, 2011, FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma, J. Clin. Oncol., 29, 3852, 10.1200/JCO.2011.36.2798 Cho, 2011, Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome, J. Clin. Oncol., 29, 1424, 10.1200/JCO.2010.28.5148 Ellison, 2011, Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups, Acta Neuropathol., 121, 381, 10.1007/s00401-011-0800-8 Schwalbe, 2017, Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study, Lancet Oncol., 18, 958, 10.1016/S1470-2045(17)30243-7 Gibson, 2010, Subtypes of medulloblastoma have distinct developmental origins, Nature, 468, 1095, 10.1038/nature09587 Northcott, 2012, Medulloblastomics: the end of the beginning, Nat. Rev. Canc., 12, 818, 10.1038/nrc3410 Felsher, 1999, Reversible tumorigenesis by MYC in hematopoietic lineages, Mol. Cell, 4, 199, 10.1016/S1097-2765(00)80367-6 Flores, 2004, Defining the temporal requirements for Myc in the progression and maintenance of skin neoplasia, Oncogene, 23, 5923, 10.1038/sj.onc.1207796 Jain, 2002, Sustained loss of a neoplastic phenotype by brief inactivation of MYC, Science, 297, 102, 10.1126/science.1071489 Soucek, 2008, Modelling Myc inhibition as a cancer therapy, Nature, 455, 679, 10.1038/nature07260 Sodir, 2011, Endogenous Myc maintains the tumor microenvironment, Genes Dev., 25, 907, 10.1101/gad.2038411 Beroukhim, 2010, The landscape of somatic copy-number alteration across human cancers, Nature, 463, 899, 10.1038/nature08822 Nesbit, 1999, MYC oncogenes and human neoplastic disease, Oncogene, 18, 3004, 10.1038/sj.onc.1202746 Eilers, 2008, Myc's broad reach, Genes Dev., 22, 2755, 10.1101/gad.1712408 Meyer, 2008, Reflecting on 25 years with MYC, Nat. Rev. Canc., 8, 976, 10.1038/nrc2231 Pomerantz, 2009, The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer, Nat. Genet., 41, 882, 10.1038/ng.403 Wright, 2010, Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells, Mol. Cell Biol., 30, 1411, 10.1128/MCB.01384-09 Dang, 2012, MYC on the path to cancer, Cell, 149, 22, 10.1016/j.cell.2012.03.003 Amati, 2001, Function of the c-Myc oncoprotein in chromatin remodeling and transcription, Biochim. Biophys. Acta, 1471, M135 Dai, 2008, Crosstalk between c-Myc and ribosome in ribosomal biogenesis and cancer, J. Cell. Biochem., 105, 670, 10.1002/jcb.21895 Hoffman, 2008, Apoptotic signaling by c-MYC, Oncogene, 27, 6462, 10.1038/onc.2008.312 van Riggelen, 2010, MYC as a regulator of ribosome biogenesis and protein synthesis, Nat. Rev. Canc., 10, 301, 10.1038/nrc2819 Dang, 2010, Rethinking the Warburg effect with Myc micromanaging glutamine metabolism, Cancer Res., 70, 859, 10.1158/0008-5472.CAN-09-3556 Dang, 2006, The c-Myc target gene network, Semin. Canc. Biol., 16, 253, 10.1016/j.semcancer.2006.07.014 Ji, 2011, Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation, PLoS One, 6, 10.1371/journal.pone.0026057 Kim, 2006, Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification, Oncogene, 25, 130, 10.1038/sj.onc.1208997 Schlosser, 2005, Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line, Oncogene, 24, 520, 10.1038/sj.onc.1208198 Schuhmacher, 2001, The transcriptional program of a human B cell line in response to Myc, Nucleic Acids Res., 29, 397, 10.1093/nar/29.2.397 Zeller, 2003, An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets, Genome Biol., 4, R69, 10.1186/gb-2003-4-10-r69 Chandriani, 2009, A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response, PLoS One, 4, e6693, 10.1371/journal.pone.0006693 Cwiek, 2015, RNA interference screening identifies a novel role for PCTK1/CDK16 in medulloblastoma with c-Myc amplification, Oncotarget, 6, 116, 10.18632/oncotarget.2699 Littlewood, 1995, A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins, Nucleic Acids Res., 23, 1686, 10.1093/nar/23.10.1686 Lewinska, 2017, Sulforaphane-induced cell cycle arrest and senescence are accompanied by DNA hypomethylation and changes in microRNA profile in breast cancer cells, Theranostics, 7, 3461, 10.7150/thno.20657 Lewinska, 2019, Snake venoms promote stress-induced senescence in human fibroblasts, J. Cell. Physiol., 234, 6147, 10.1002/jcp.27382 Lewinska, 2018, Reduced levels of methyltransferase DNMT2 sensitize human fibroblasts to oxidative stress and DNA damage that is accompanied by changes in proliferation-related miRNA expression, Redox Biol., 14, 20, 10.1016/j.redox.2017.08.012 Lewinska, 2017, Phytochemical-induced nucleolar stress results in the inhibition of breast cancer cell proliferation, Redox Biol., 12, 469, 10.1016/j.redox.2017.03.014 Lewinska, 2017, Downregulation of methyltransferase Dnmt2 results in condition-dependent telomere shortening and senescence or apoptosis in mouse fibroblasts, J. Cell. Physiol., 232, 3714, 10.1002/jcp.25848 Salm, 2015, The phosphoinositide 3-kinase p110alpha isoform regulates leukemia inhibitory factor receptor expression via c-myc and miR-125b to promote cell proliferation in medulloblastoma, PLoS One, 10, 10.1371/journal.pone.0123958 Zhou, 2010, Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma, Cancer Res., 70, 8199, 10.1158/0008-5472.CAN-09-4562 Chang, 2015, The actin depolymerizing factor (ADF)/cofilin signaling pathway and DNA damage responses in cancer, Int. J. Mol. Sci., 16, 4095, 10.3390/ijms16024095 Olson, 2004, Sensing cellular stress: another new function for the nucleolus?, Sci. STKE, 10.1126/stke.2242004pe10 Bamburg, 1999, Proteins of the ADF/cofilin family: essential regulators of actin dynamics, Annu. Rev. Cell Dev. Biol., 15, 185, 10.1146/annurev.cellbio.15.1.185 Carlier, 1999, Control of actin dynamics in cell motility. Role of ADF/cofilin, J. Biol. Chem., 274, 33827, 10.1074/jbc.274.48.33827 Elam, 2013, Biophysics of actin filament severing by cofilin, FEBS Lett., 587, 1215, 10.1016/j.febslet.2013.01.062 Bravo-Cordero, 2013, Functions of cofilin in cell locomotion and invasion, Nat. Rev. Mol. Cell Biol., 14, 405, 10.1038/nrm3609 Narumiya, 2009, Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion, Cancer Metastasis Rev., 28, 65, 10.1007/s10555-008-9170-7 Bernstein, 2010, ADF/cofilin: a functional node in cell biology, Trends Cell Biol., 20, 187, 10.1016/j.tcb.2010.01.001 Besson, 2008, CDK inhibitors: cell cycle regulators and beyond, Dev. Cell, 14, 159, 10.1016/j.devcel.2008.01.013 Starostina, 2012, Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors, Trends Cell Biol., 22, 33, 10.1016/j.tcb.2011.10.004 Wang, 2007, The cofilin pathway in breast cancer invasion and metastasis, Nat. Rev. Canc., 7, 429, 10.1038/nrc2148 Abe, 1993, Cytoplasmic localization and nuclear transport of cofilin in cultured myotubes, Exp. Cell Res., 206, 1, 10.1006/excr.1993.1113 Pendleton, 2003, Latrunculin B or ATP depletion induces cofilin-dependent translocation of actin into nuclei of mast cells, J. Biol. Chem., 278, 14394, 10.1074/jbc.M206393200 Munsie, 2012, Cofilin nuclear-cytoplasmic shuttling affects cofilin-actin rod formation during stress, J. Cell Sci., 125, 3977, 10.1242/jcs.097667 Obrdlik, 2011, The F-actin severing protein cofilin-1 is required for RNA polymerase II transcription elongation, Nucleus, 2, 72, 10.4161/nucl.14508 Freund, 2012, Lamin B1 loss is a senescence-associated biomarker, Mol. Biol. Cell, 23, 2066, 10.1091/mbc.e11-10-0884 Sikora, 2011, Impact of cellular senescence signature on ageing research, Ageing Res. Rev., 10, 146, 10.1016/j.arr.2010.10.002 Malhas, 2009, Lamin B1 controls oxidative stress responses via Oct-1, J. Cell Biol., 184, 45, 10.1083/jcb.200804155 Andrin, 2012, A requirement for polymerized actin in DNA double-strand break repair, Nucleus, 3, 384, 10.4161/nucl.21055 Stewart, 2009, Solving the RIDDLE of 53BP1 recruitment to sites of damage, Cell Cycle, 8, 1532, 10.4161/cc.8.10.8351 Karlseder, 2004, The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response, PLoS Biol., 2, E240, 10.1371/journal.pbio.0020240 Walker, 2012, Post-translational modifications of TRF1 and TRF2 and their roles in telomere maintenance, Mech. Ageing Dev., 133, 421, 10.1016/j.mad.2012.05.002 Zhang, 2005, Up-regulation of telomere-binding TRF1, TRF2 related to reactive oxygen species induced by As(2)O(3) in MGC-803 cells, Eur. J. Pharmacol., 516, 1, 10.1016/j.ejphar.2005.04.022 Schaefer, 2010, Solving the Dnmt2 enigma, Chromosoma, 119, 35, 10.1007/s00412-009-0240-6 Mytych, 2014, Nanodiamond-mediated impairment of nucleolar activity is accompanied by oxidative stress and DNMT2 upregulation in human cervical carcinoma cells, Chem. Biol. Interact., 220, 51, 10.1016/j.cbi.2014.06.004 Grummt, 2013, The nucleolus-guardian of cellular homeostasis and genome integrity, Chromosoma, 122, 487, 10.1007/s00412-013-0430-0